# US 8,278,415 B2 · Dimeric high affinity EGFR constructs and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,415 B2
- Document ID: US8278415B2
- Status: Granted
- Kind: B2
- Application number: 12/514,631
- Filed: 2007-12-20
- Published: 2010-04-22
- Granted: 2012-10-02
- Earliest claimed: 2006-12-21
- Assignees: Centocor, Inc.
- Inventors: Wang Bryan; Frank Shi; Juliane Mills
- Web page: https://patentgrep.com/patent/US8278415B2

## CPC

- C07K 14/71: for growth factors; for growth regulators
- A61P 31/12: Antivirals
- A61P 35/00: Antineoplastic agents
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K 2319/30: Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Polypeptides comprising EGFR extracellular domains I-III capable of forming dimeric EGF-binding proteins are provided. The dimeric construct of the invention is useful in applications where high affinity EGF binding is desired and can be used to select agents capable of binding to native EGFR in the presence of EGF.

## Claims

### Claim 1

A composition comprising a fusion protein according to the formula:
V1o-Pepa-Flexn-V2m-Hinge-CH2-CH3 (I)
and wherein Pep represents domains I to III of human EGFR capable of binding EGF with an affinity of less than 1 nM when measured by BIAcore, V1 is the sequence QIQ, Flex is a flexible linker peptide, V2 represents a sequence derived from an immunoglobulin J gene domain and is TLVTVSS (SEQ ID No:61), the hinge, CH2 and CH3 are domains from a human IgG1 and each of a, m, n and o is equal to 1, wherein the fusion protein comprises SEQ ID NO:2.

### Claim 2

A dimeric polypeptide comprising two polypeptides of sequence SEQ ID NO:2.
